Lactulose
- Generic Name
- Lactulose
- Brand Names
- Constulose, Enulose, Generlac, Kristalose
- Drug Type
- Small Molecule
- Chemical Formula
- C12H22O11
- CAS Number
- 4618-18-2
- Unique Ingredient Identifier
- 9XH2P2N8EP
- Background
Lactulose is a synthetic disaccharide derivative of lactose that is most commonly used as a laxative agent despite also being formally indicated to serve as an adjunct therapy in treating portal-systemic encephalopathy (PSE). Despite being first synthesized in 1929, investigations regarding its possible use as a laxative for the treatment of chronic constipa...
- Indication
Lactulose is indicated for use as a laxative in the treatment of chronic constipation in adults and geriatric patients.
...
- Associated Conditions
- Constipation, Hepatic Encephalopathy (HE)
- Associated Therapies
- -
Lactulose for the Prevention of Nosocomial Infections in Children
Not Applicable
- Conditions
- First Posted Date
- 2006-01-10
- Last Posted Date
- 2008-02-06
- Lead Sponsor
- Bnai Zion Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT00273949
- Locations
- 🇮🇱
Pediatric Department, Bnai Zion Medical Center, Haifa, Israel
Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal Fissures
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2008-05-06
- Lead Sponsor
- Solvay Pharmaceuticals
- Target Recruit Count
- 97
- Registration Number
- NCT00160290
- Locations
- 🇪🇸
Site 6, Granada, Spain
🇪🇸Site 2, Barcelona, Spain
🇪🇸Site 5, Huesca, Spain
Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis
Phase 2
Completed
- Conditions
- First Posted Date
- 2000-02-25
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Center for Research Resources (NCRR)
- Target Recruit Count
- 16
- Registration Number
- NCT00004796
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath